Skip to main content

Table 3 Shows %-values of G1-, S-, G2-phase cells of two different rhabdoid tumor cell lines (A204, G401) treated with 10 μM SAHA for 18 h or 72 h

From: The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells

Cell line

G1-phase %

S-phase %

G2-phase %

A204 control

57.0 +/− 1.2

21.1 +/− 0.9

22.0 +/− 2.3

A204 SAHA 18 h

43.3 +/− 2.1

10.5 +/− 0.6

46.3 +/− 3.4

A204 SAHA 72 h

79.1 +/− 1.9

5.3 +/− 0.4

15.6 +/− 0.9

G401 control

45.8 +/− 1.0

39.2 +/− 1.6

14.9 +/− 0.9

G401 SAHA 18 h

56.4 +/− 7.6

12.8 +/− 0.2

30.8 +/− 2.6

G401 SAHA 72 h

76.2 +/− 5.5

10.3 +/− 2.8

13.5 +/− 0.6